دورية أكاديمية
Impact of Obesity on Cardiac Volumes and Left Ventricular Diameter: A Cross-Sectional Study in an Iranian Heart Center.
| العنوان: | Impact of Obesity on Cardiac Volumes and Left Ventricular Diameter: A Cross-Sectional Study in an Iranian Heart Center. |
|---|---|
| المؤلفون: | Omidi F; Department of Cardiology, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Nasiri MJ; School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Sadeghi S; Clinical Research Development Center, Imam Hossein Educational Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran. |
| المصدر: | Advances in medicine [Adv Med] 2024 Jun 12; Vol. 2024, pp. 7038875. Date of Electronic Publication: 2024 Jun 12 (Print Publication: 2024). |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Hindawi Publishing Corporation Country of Publication: United States NLM ID: 101651448 Publication Model: eCollection Cited Medium: Internet ISSN: 2314-758X (Electronic) Linking ISSN: 2314758X NLM ISO Abbreviation: Adv Med Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: New York, NY : Hindawi Publishing Corporation, [2014]- |
| مستخلص: | Introduction: Obesity, a pressing global health issue worldwide, contributes to risk factors such as hypertension and dyslipidemia, creating an unfavorable cardiovascular environment and increasing the likelihood of adverse cardiac events. His study aims to assess the impact of obesity on various cardiovascular parameters. Methods: A cross-sectional analysis was conducted at a Heart Center, focusing on adults admitted for suspected heart diseases. The dataset included information on demographics, clinical history, laboratory results, and echocardiography. Descriptive analysis and multiple linear regression were employed using IBM SPSS Statistics version 26. Results: The study of 105 individuals with suspected heart diseases revealed prevalent health factors such as hypertension (47.6%) and hyperlipidemia (61%). Body mass index (BMI) averaged 30, indicating a trend toward overweight. Obesity significantly associated with higher systolic blood pressure (SBP, p =0.005) and diastolic blood pressure (DBP, p =0.002), larger cardiac volumes (end-diastolic volume, EDV, p =0.013; end-systolic volume, ESV, p =0.040), and a marginally significant influence on left ventricular end-diastolic diameter (LVEDD, p =0.068). No significant associations were found with left ventricular end-systolic diameter (LVEDS), heart rate (HR), or ejection fraction (EF). Conclusions: Our study highlights a significant association between obesity and elevated blood pressure, larger cardiac volumes, and a marginal impact on left ventricular end-diastolic diameter. While caution is needed in inferring causation due to the study's cross-sectional nature, these findings underscore the importance of addressing obesity as a potential risk factor for adverse cardiovascular outcomes. Further investigations are warranted to enhance our understanding of the complex interplay between obesity and cardiovascular health. Competing Interests: The authors declare that they have no conflicts of interest. (Copyright © 2024 Fatemeh Omidi et al.) |
| References: | N Engl J Med. 2017 Jul 6;377(1):80-81. (PMID: 28604226) Sci Rep. 2022 Jan 18;12(1):927. (PMID: 35042940) Int J Mol Sci. 2021 Oct 27;22(21):. (PMID: 34769060) N Engl J Med. 2023 Dec 14;389(24):2221-2232. (PMID: 37952131) Circulation. 2021 May 25;143(21):e984-e1010. (PMID: 33882682) Med Clin North Am. 2021 Jan;105(1):149-174. (PMID: 33246516) Curr Cardiol Rep. 2020 Mar 12;22(4):25. (PMID: 32166448) Curr Obes Rep. 2023 Sep;12(3):207-222. (PMID: 37410248) Nutrients. 2020 May 03;12(5):. (PMID: 32375231) Eur Heart J. 2023 Jun 20;44(23):2066-2077. (PMID: 36342266) Obes Rev. 2022 Jan;23(1):e13349. (PMID: 34708499) Med J Aust. 2023 Apr 3;218(6):276-283. (PMID: 36934408) Prog Cardiovasc Dis. 2023 May-Jun;78:2-10. (PMID: 36481212) Nat Rev Endocrinol. 2013 Jan;9(1):13-27. (PMID: 23165161) Curr Obes Rep. 2020 Dec;9(4):571-581. (PMID: 32870465) Cardiovasc Diabetol. 2020 Jun 13;19(1):79. (PMID: 32534575) Mt Sinai J Med. 2010 Sep-Oct;77(5):511-23. (PMID: 20960553) Nat Rev Endocrinol. 2019 May;15(5):288-298. (PMID: 30814686) Obes Facts. 2023;16(1):11-28. (PMID: 36521448) J Am Coll Cardiol. 2023 Feb 7;81(5):490-504. (PMID: 36725178) Eur J Clin Invest. 2023 Mar;53(3):e13912. (PMID: 36424669) JAMA. 2017 Aug 15;318(7):603. (PMID: 28810033) Healthcare (Basel). 2023 Mar 21;11(6):. (PMID: 36981559) Eur J Prev Cardiol. 2023 Mar 1;30(4):331-339. (PMID: 36447442) Physiol Rev. 2021 Oct 1;101(4):1745-1807. (PMID: 33949876) |
| تواريخ الأحداث: | Date Created: 20240620 Latest Revision: 20240621 |
| رمز التحديث: | 20240621 |
| مُعرف محوري في PubMed: | PMC11186677 |
| DOI: | 10.1155/2024/7038875 |
| PMID: | 38899165 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2314-758X |
|---|---|
| DOI: | 10.1155/2024/7038875 |